The government aims to establish 25,000 Jan Aushadhi Kendras nationwide by March 31, 2027. Currently, there are 15,000 of these outlets providing affordable medicines and medical devices.
Initiated by the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers in 2008, the scheme focuses on offering low-cost generic medications. The range has expanded to include 2,047 different drugs and 300 types of surgical equipment, with prices ranging from 50% to 80% less than those of branded products, according to a statement from the Ministry. Remarkably, the original goal of opening 15,000 Kendras by March 2025 was accomplished ahead of schedule by January 31, 2025.
The initiative encompasses 29 therapeutic categories, including antibiotics, anti-cancer treatments, anti-diabetics, cardiovascular medications, analgesics, anti-allergic substances, gastrointestinal agents, vitamins and minerals, as well as food supplements and topical medicines. The medical devices available through this program encompass surgical equipment and essential consumables such as masks, orthopedic rehabilitation products, surgical dressings, syringes, needles, sanitary napkins, sutures, diapers, rubber gloves, oximeters, and rapid antigen test kits.
In the financial year 2023-24, sales from this initiative reached ₹1,470 crore, resulting in approximately ₹7,350 crore in savings for citizens. As of February 28, 2025, sales have continued to grow, totaling ₹1,760 crore in the current financial year, 2024-25.
Over the past decade, the number of Kendras has surged by 180 times, with sales increasing more than 200 times, leading to an estimated savings of around ₹30,000 crore for citizens. This information was presented by the Ministry as Union Minister of Chemicals and Fertilizers and Health and Family Welfare, JP Nadda, inaugurated a week-long celebration in anticipation of Jan Aushadhi Diwas.